{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T12:12:10Z","timestamp":1776255130912,"version":"3.50.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:00:00Z","timestamp":1773014400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key R&D Program of China","doi-asserted-by":"crossref","award":["2021YFC2702005"],"award-info":[{"award-number":["2021YFC2702005"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National High Level Hospital Clinical Research Funding","award":["2025-PUMCH-C-047"],"award-info":[{"award-number":["2025-PUMCH-C-047"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Rheumatol"],"DOI":"10.1186\/s12969-026-01204-9","type":"journal-article","created":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T09:15:30Z","timestamp":1773047730000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Natural killer cells as biomarkers for disease activity, lupus nephritis, and time to remission in treatment-na\u00efve childhood-onset systemic lupus erythematosus: a cohort study"],"prefix":"10.1186","volume":"24","author":[{"given":"Tianyi","family":"Luo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sihao","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siming","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yufan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caihui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongxun","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingsheng","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongmei","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,9]]},"reference":[{"key":"1204_CR1","doi-asserted-by":"publisher","first-page":"108274","DOI":"10.1016\/j.clim.2019.108274","volume":"209","author":"E Smith","year":"2019","unstructured":"Smith E, Lythgoe H, Midgley A, Beresford MW, Hedrich CM. Juvenile-onset systemic lupus erythematosus: Update on clinical presentation, pathophysiology and treatment options. Clin Immunol. 2019;209:108274.","journal-title":"Clin Immunol"},{"issue":"10","key":"1204_CR2","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/S2352-4642(24)00172-X","volume":"8","author":"S Gao","year":"2024","unstructured":"Gao S, Yu Z, Ma X, Sun J, Ren A, Gao S, et al. Childhood-onset systemic lupus erythematosus in China, 2016-21: a nationwide study. Lancet Child Adolesc Health. 2024;8(10):762\u201372.","journal-title":"Lancet Child Adolesc Health"},{"issue":"4","key":"1204_CR3","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1189\/jlb.4RU0315-081RR","volume":"98","author":"R Spada","year":"2015","unstructured":"Spada R, Rojas JM, Barber DF. Recent findings on the role of natural killer cells in the pathogenesis of systemic lupus erythematosus. J Leukoc Biol. 2015;98(4):479\u201387.","journal-title":"J Leukoc Biol"},{"issue":"5","key":"1204_CR4","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/j.cell.2018.07.017","volume":"174","author":"E Vivier","year":"2018","unstructured":"Vivier E, Artis D, Colonna M, Diefenbach A, Di Santo JP, Eberl G, et al. Innate Lymphoid Cells: 10 Years On. Cell. 2018;174(5):1054\u201366.","journal-title":"Cell"},{"issue":"8000","key":"1204_CR5","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/s41586-023-06945-1","volume":"626","author":"E Vivier","year":"2024","unstructured":"Vivier E, Rebuffet L, Narni-Mancinelli E, Cornen S, Igarashi RY, Fantin VR. Natural killer cell therapies. Nature. 2024;626(8000):727\u201336.","journal-title":"Nature"},{"issue":"8","key":"1204_CR6","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1038\/s41590-024-01883-0","volume":"25","author":"L Rebuffet","year":"2024","unstructured":"Rebuffet L, Melsen JE, Escaliere B, Basurto-Lozada D, Bhandoola A, Bjorkstrom NK, et al. High-dimensional single-cell analysis of human natural killer cell heterogeneity. Nat Immunol. 2024;25(8):1474\u201388.","journal-title":"Nat Immunol"},{"issue":"9","key":"1204_CR7","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1177\/096120339700600905","volume":"6","author":"FM Erkeller-Yuksel","year":"1997","unstructured":"Erkeller-Yuksel FM, Lydyard PM, Isenberg DA. Lack of NK cells in lupus patients with renal involvement. Lupus. 1997;6(9):708\u201312.","journal-title":"Lupus"},{"issue":"5","key":"1204_CR8","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1191\/096120300678828460","volume":"9","author":"V Riccieri","year":"2000","unstructured":"Riccieri V, Spadaro A, Parisi G, Taccari E, Moretti T, Bernardini G, et al. Down-regulation of natural killer cells and of gamma\/delta T cells in systemic lupus erythematosus. Does it correlate to autoimmunity and to laboratory indices of disease activity? Lupus. 2000;9(5):333\u20137.","journal-title":"Lupus"},{"issue":"6","key":"1204_CR9","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1002\/art.24556","volume":"60","author":"YW Park","year":"2009","unstructured":"Park YW, Kee SJ, Cho YN, Lee EH, Lee HY, Kim EM, et al. Impaired differentiation and cytotoxicity of natural killer cells in systemic lupus erythematosus. Arthritis Rheum. 2009;60(6):1753\u201363.","journal-title":"Arthritis Rheum"},{"issue":"3","key":"1204_CR10","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s00005-019-00537-6","volume":"67","author":"AM Zahran","year":"2019","unstructured":"Zahran AM, Abdel-Rahim MH, Elsayh KI, Hassanien MM, Mahran SA, Hetta HF. Natural Killer and Natural Killer T Cells in Juvenile Systemic Lupus Erythematosus: Relation to Disease Activity and Progression. Arch Immunol Ther Exp (Warsz). 2019;67(3):161\u20139.","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"issue":"1","key":"1204_CR11","doi-asserted-by":"publisher","first-page":"13074","DOI":"10.1038\/s41598-024-62325-3","volume":"14","author":"A Radziszewska","year":"2024","unstructured":"Radziszewska A, Peckham H, de Gruijter NM, Restuadi R, Wu WH, Jury EC, et al. Active juvenile systemic lupus erythematosus is associated with distinct NK cell transcriptional and phenotypic alterations. Sci Rep. 2024;14(1):13074.","journal-title":"Sci Rep"},{"key":"1204_CR12","doi-asserted-by":"publisher","first-page":"1327255","DOI":"10.3389\/fimmu.2024.1327255","volume":"15","author":"BL Liphaus","year":"2024","unstructured":"Liphaus BL, Silva SC, Palmeira P, Silva CA, Goldenstein-Schainberg C, Carneiro-Sampaio M. Reduced expressions of apoptosis-related proteins TRAIL, Bcl-2, and TNFR1 in NK cells of juvenile-onset systemic lupus erythematosus patients: relations with disease activity, nephritis, and neuropsychiatric involvement. Front Immunol. 2024;15:1327255.","journal-title":"Front Immunol"},{"issue":"1","key":"1204_CR13","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12969-023-00807-w","volume":"21","author":"T Zhang","year":"2023","unstructured":"Zhang T, Yu Z, Gao S, Zhang Y, Wang C, Jian S, et al. Clinical phenotypes and prognosis of cytomegalovirus infection in the pediatric systemic lupus erythematosus: a longitudinal analysis. Pediatr Rheumatol Online J. 2023;21(1):25.","journal-title":"Pediatr Rheumatol Online J"},{"issue":"11","key":"1204_CR14","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/s41584-024-01167-9","volume":"20","author":"WH Robinson","year":"2024","unstructured":"Robinson WH, Younis S, Love ZZ, Steinman L, Lanz TV. Epstein-Barr virus as a potentiator of autoimmune diseases. Nat Rev Rheumatol. 2024;20(11):729\u201340.","journal-title":"Nat Rev Rheumatol"},{"issue":"9","key":"1204_CR15","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1002\/art.1780400928","volume":"40","author":"MC Hochberg","year":"1997","unstructured":"Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40(9):1725.","journal-title":"Arthritis Rheum"},{"issue":"9","key":"1204_CR16","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1002\/art.40930","volume":"71","author":"M Aringer","year":"2019","unstructured":"Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey-Goldman R, et al. 2019 European League Against Rheumatism\/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus. Arthritis Rheumatol. 2019;71(9):1400\u201312.","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"1204_CR17","doi-asserted-by":"crossref","first-page":"e538","DOI":"10.1136\/lupus-2021-000538","volume":"8","author":"RF van Vollenhoven","year":"2021","unstructured":"van Vollenhoven RF, Bertsias G, Doria A, Isenberg D, Morand E, Petri MA, et al. 2021 DORIS definition of remission in SLE: final recommendations from an international task force. Lupus Sci Med. 2021;8(1):e538.","journal-title":"Lupus Sci Med"},{"issue":"2","key":"1204_CR18","first-page":"88","volume":"56","author":"Subspecialty Group Of Renal Diseases TSOP","year":"2018","unstructured":"Subspecialty Group Of Renal Diseases TSOP. Evidence-based guideline on diagnosis and treatment of lupus nephritis (2016). Zhonghua er ke za zhi\u2009=\u2009Chinese. J Pediatr. 2018;56(2):88\u201394.","journal-title":"J Pediatr"},{"issue":"3","key":"1204_CR19","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1016\/j.jaci.2018.04.022","volume":"142","author":"Y Ding","year":"2018","unstructured":"Ding Y, Zhou L, Xia Y, Wang W, Wang Y, Li L, et al. Reference values for peripheral blood lymphocyte subsets of healthy children in China. J Allergy Clin Immunol. 2018;142(3):970\u20133.","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"1204_CR20","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1002\/art.30313","volume":"63","author":"B Hervier","year":"2011","unstructured":"Hervier B, Beziat V, Haroche J, Mathian A, Lebon P, Ghillani-Dalbin P, et al. Phenotype and function of natural killer cells in systemic lupus erythematosus: excess interferon-gamma production in patients with active disease. Arthritis Rheum. 2011;63(6):1698\u2013706.","journal-title":"Arthritis Rheum"},{"issue":"10","key":"1204_CR21","first-page":"e46885","volume":"15","author":"N Thangjam","year":"2023","unstructured":"Thangjam N, Dey B, Khonglah Y, Tiewsoh I, Ksoo R. Natural Killer Cell Count in Systemic Lupus Erythematosus Patients: A Flow Cytometry-Based Study. Cureus. 2023;15(10):e46885.","journal-title":"Cureus"},{"issue":"9","key":"1204_CR22","first-page":"1768","volume":"41","author":"H Li","year":"2023","unstructured":"Li H, Geng L, Cao Z, Jin Z, Yan Q, Long X, et al. CD56brightCD16\u2013 to CD57+CD56dimCD16+ NK cell ratio discriminates disease activity and renal involvement in patients with systemic lupus erythematosus. Clin Exp Rheumatol. 2023;41(9):1768\u201376.","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"1204_CR23","doi-asserted-by":"publisher","first-page":"e1250","DOI":"10.1002\/cti2.1250","volume":"10","author":"Y Yang","year":"2021","unstructured":"Yang Y, Day J, Souza-Fonseca Guimaraes F, Wicks IP, Louis C. Natural killer cells in inflammatory autoimmune diseases. Clin Transl Immunol. 2021;10(2):e1250.","journal-title":"Clin Transl Immunol"},{"issue":"23","key":"1204_CR24","doi-asserted-by":"publisher","first-page":"e182390","DOI":"10.1172\/jci.insight.182390","volume":"9","author":"C Coyle","year":"2024","unstructured":"Coyle C, Ma M, Abraham Y, Mahony CB, Steel K, Simpson C, et al. NK cell subsets define sustained remission in rheumatoid arthritis. JCI insight. 2024;9(23):e182390.","journal-title":"JCI insight"},{"key":"1204_CR25","doi-asserted-by":"publisher","first-page":"611522","DOI":"10.3389\/fimmu.2020.611522","volume":"11","author":"L Gomez-Munoz","year":"2020","unstructured":"Gomez-Munoz L, Perna-Barrull D, Villalba A, Rodriguez-Fernandez S, Ampudia RM, Teniente-Serra A, et al. NK Cell Subsets Changes in Partial Remission and Early Stages of Pediatric Type 1 Diabetes. Front Immunol. 2020;11:611522.","journal-title":"Front Immunol"}],"container-title":["Pediatric Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12969-026-01204-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-026-01204-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-026-01204-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T11:27:09Z","timestamp":1776252429000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12969-026-01204-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,9]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1204"],"URL":"https:\/\/doi.org\/10.1186\/s12969-026-01204-9","relation":{},"ISSN":["1546-0096"],"issn-type":[{"value":"1546-0096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,9]]},"assertion":[{"value":"7 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College (JS-3362D). As this was a retrospective study, the requirement for informed consent was waived by the ethics committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Patients and\/or the public were not involved in the design, or conduct, or reporting, or dissemination plans of this research.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient and public involvement"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"24"}}